Thousands of women with advanced breast cancer could be denied life-extending drugs because of the “unfair” way they are ...

A mum from Banbury with breast cancer said a life-extending drug would be 'worth it', as a charity speaks out on the 'unfair' ...

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England. In a ...

AstraZeneca's oral therapy Truqap will soon be available for people with advanced breast cancer via the NHS in England – as long as testing is available to identify eligible patients.

A ground-breaking breast cancer treatment programme, funded by Cancer Research UK, that could potentially save thousands of ...

A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world first. It can halt the blood cancer myeloma for nearly three times ...

June 13 (UPI) -- England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer therapy that can stop progression of the cancer for ...

Professor Peter Johnson, NHS England’s cancer director, said: “Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent ...

Women aged 25–49 years living in England considered at low risk of cervical cancer following testing will now be invited for screening every 5 years instead of every 3 years. The changes, announced by ...